Orme JJ - Search Results

1

HUS1 as a Potential Therapeutic Target in Urothelial Cancer.

Lindner AK, Furlan T, Orme JJ, Tulchiner G, Staudacher N, D'Andrea D, Culig Z, Pichler R. Lindner AK, et al. Among authors: orme jj. J Clin Med. 2022 Apr 15;11(8):2208. doi: 10.3390/jcm11082208. J Clin Med. 2022. PMID: 35456300 Free PMC article.

2

CMTM6 expression as a potential biomarker for immunotherapy in metastatic renal cell carcinoma.

Tulchiner G, Brunner A, Schmidinger M, Staudacher N, Orme JJ, Thurnher M, Horninger W, Culig Z, Pichler R. Tulchiner G, et al. Among authors: orme jj. BJU Int. 2021 Jul;128(1):29-32. doi: 10.1111/bju.15341. Epub 2021 Feb 7. BJU Int. 2021. PMID: 33455021 Free PMC article. No abstract available.

3

Expression of ADAM Proteases in Bladder Cancer Patients with BCG Failure: A Pilot Study.

Pichler R, Lindner AK, Schäfer G, Tulchiner G, Staudacher N, Mayr M, Comperat E, Orme JJ, Schachtner G, Thurnher M. Pichler R, et al. Among authors: orme jj. J Clin Med. 2021 Feb 14;10(4):764. doi: 10.3390/jcm10040764. J Clin Med. 2021. PMID: 33672843 Free PMC article.

4

Reversibility of Bicalutamide PSMA PET-Positive Gynecomastia With Androgen Deprivation Therapy.

Muniz M, Childs DS, Orme JJ, Johnson GB, Sartor O. Muniz M, et al. Among authors: orme jj. Clin Nucl Med. 2024 Apr 1;49(4):e164-e165. doi: 10.1097/RLU.0000000000005084. Epub 2024 Feb 6. Clin Nucl Med. 2024. PMID: 38377363

5

Chemotherapy with atezolizumab for small cell or neuroendocrine carcinoma of the prostate: A single institution experience.

Wee CE, Costello BA, Orme JJ, Quevedo JF, Pagliaro LC. Wee CE, et al. Among authors: orme jj. Prostate. 2021 Sep;81(13):938-943. doi: 10.1002/pros.24189. Epub 2021 Jul 12. Prostate. 2021. PMID: 34254332

6

Rational Second-Generation Antiandrogen Use in Prostate Cancer.

Orme JJ, Pagliaro LC, Quevedo JF, Park SS, Costello BA. Orme JJ, et al. Oncologist. 2022 Mar 4;27(2):110-124. doi: 10.1093/oncolo/oyab045. Oncologist. 2022. PMID: 35641216 Free PMC article.

7

Evaluation of PD-L1 and B7-H3 expression as a predictor of response to adjuvant chemotherapy in bladder cancer.

Mahmoud AM, Frank I, Orme JJ, Lavoie RR, Thapa P, Costello BA, Cheville JC, Gupta S, Dong H, Lucien F. Mahmoud AM, et al. Among authors: orme jj. BMC Urol. 2022 Jun 24;22(1):90. doi: 10.1186/s12894-022-01044-1. BMC Urol. 2022. PMID: 35751046 Free PMC article.

8

Radiation Therapy in Oligometastatic Prostate Cancer.

Chinniah S, Stish B, Costello BA, Pagliaro L, Childs D, Quevedo F, Lucien F, Bryce A, Park SS, Orme JJ. Chinniah S, et al. Among authors: orme jj. Int J Radiat Oncol Biol Phys. 2022 Nov 15;114(4):684-692. doi: 10.1016/j.ijrobp.2022.07.014. Epub 2022 Jul 22. Int J Radiat Oncol Biol Phys. 2022. PMID: 35878715 Free article. Review.

9

Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung Cancer.

Desai A, Smith CJ, Ashara Y, Orme JJ, Zanwar S, Potter A, Hocum C, Moffett JN, Schwecke AJ, Manochakian R, Lou Y, Zhao Y, Ernani V, Savvides P, Molina J, Dimou A, Mansfield AS, Parikh K, Leventakos K. Desai A, et al. Among authors: orme jj. Clin Lung Cancer. 2023 Dec;24(8):689-695.e1. doi: 10.1016/j.cllc.2023.09.001. Epub 2023 Sep 17. Clin Lung Cancer. 2023. PMID: 37880074 Free article.

10

Prostate Cancer and Malignant Ascites: The Mayo Clinic Experience With a Rare and Aggressive Disease Progression.

Mahmoud AM, Orme JJ, Childs DS, Ahmed ME, Rajkumar A, Kwon ED, Andrews JR. Mahmoud AM, et al. Among authors: orme jj. Clin Genitourin Cancer. 2024 Apr;22(2):291-294. doi: 10.1016/j.clgc.2023.11.011. Epub 2023 Nov 23. Clin Genitourin Cancer. 2024. PMID: 38101982 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters